A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Clinical trial NCT07365241 · RECRUITING
Trial details
- NCT number
- NCT07365241
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-02
- Primary completion
- 2030-09-01
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.